Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02004-18. Print 2019 Mar.
Infections caused by the coexistence of echinocandin-resistant and echinocandin-susceptible cells may be possible, and the detection of mutants when the proportions of mutants are underrepresented poses a problem. We assessed the role of EUCAST and methods directly performed on positive blood cultures-Etest (ET) and anidulafungin-containing agar plate assays-for detecting resistance in isolates containing different amounts of echinocandin-susceptible and -resistant isolates. We studied 10 pairs of isolates involving parental echinocandin-susceptible isolates and isogenic echinocandin-resistant mutant isolates. Three inocula per pair (1 × 10 to 5 × 10, 1 × 10 to 5 × 10, and 10 to 50 CFU/ml) spanning suspensions with different amounts of susceptible/resistant isolates (9/1, 5/5, and 1/9 proportions for each the three inocula) were prepared. The suspensions were spiked in Bactec bottles and incubated until they were positive, and the three methods were compared. The EUCAST method showed echinocandin resistance when the bottles were spiked with susceptible/resistant isolates at 5/5 and 1/9 proportions; the results for the suspensions with a 9/1 proportion of susceptible/resistant isolates were susceptible for three pairs. We observed with the ET resistance to both echinocandins in all pairs (resistance to micafungin and anidulafungin; MICs, ≥0.064 mg/liter and ≥0.125 mg/liter, respectively) and a double ring of growth inhibition in two pairs. The anidulafungin-containing plates showed fungal growth in the 90 spiked blood cultures at 48 h. Testing of echinocandin susceptibility with the ET directly on the positive blood culture bottles is a reliable and rapid method to detect echinocandin resistance in On the other hand, resistance can be missed with the EUCAST method when resistant isolates are underrepresented.
可能会存在棘白菌素耐药和棘白菌素敏感细胞共存引起的感染,而且当突变体的比例较低时,检测到突变体是一个问题。我们评估了 EUCAST 方法和直接在阳性血培养物上进行的方法(Etest[ET]和含阿尼芬净琼脂平板测定法)在检测含有不同数量棘白菌素敏感和耐药 分离株的分离株中的作用。我们研究了涉及亲本棘白菌素敏感分离株和同源棘白菌素耐药 突变体分离株的 10 对 分离株。每对分离株制备 3 个接种物(1×10 到 5×10、1×10 到 5×10 和 10 到 50 CFU/ml),涵盖具有不同敏感/耐药分离株数量的悬浮液(每个接种物的 3 个比例为 9/1、5/5 和 1/9)。将悬浮液加入 Bactec 瓶中孵育,直到它们变为阳性,然后比较这 3 种方法。当瓶中接种 5/5 和 1/9 比例的敏感/耐药分离株时,EUCAST 方法显示棘白菌素耐药;当接种物中敏感/耐药分离株的比例为 9/1 时,有 3 对分离株的结果为敏感。我们观察到 ET 对所有 10 对分离株均显示出对两种棘白菌素的耐药性(对米卡芬净和阿尼芬净的耐药性;MIC 值分别为≥0.064 毫克/升和≥0.125 毫克/升),并且在两对分离株中观察到双环生长抑制。含阿尼芬净的平板在 48 小时时显示 90 个阳性血培养物中有真菌生长。直接在阳性血培养瓶上用 ET 检测棘白菌素敏感性是一种可靠且快速的方法,可以检测 分离株中的棘白菌素耐药性。另一方面,当耐药分离株的比例较低时,EUCAST 方法可能会漏检耐药性。